{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:13:11Z","timestamp":1791303191517,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173078, 81100344, 81371268"],"award-info":[{"award-number":["81173078, 81100344, 81371268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2010CB912104"],"award-info":[{"award-number":["2010CB912104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bbrc.2014.05.072","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T00:18:27Z","timestamp":1401149907000},"page":"117-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction"],"prefix":"10.1016","volume":"450","author":[{"given":"Xijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"She","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.05.072_b0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.05.072_b0010","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbrc.2014.05.072_b0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.05.072_b0020","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0025","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.drudis.2012.05.012","article-title":"Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis","volume":"17","author":"Adorini","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2014.05.072_b0030","first-page":"934396","article-title":"Non-alcoholic fatty liver disease: the bile acid-activated farnesoid X receptor as an emerging treatment target","author":"Fuchs","year":"2012","journal-title":"J. Lipids"},{"key":"10.1016\/j.bbrc.2014.05.072_b0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.03.025","article-title":"Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis","volume":"51","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0040","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jevs.2012.05.004","article-title":"Fructokinase, fructans, intestinal permeability, and metabolic syndrome: an equine connection?","volume":"33","author":"Johnson","year":"2013","journal-title":"J. Equine Vet. Sci."},{"key":"10.1016\/j.bbrc.2014.05.072_b0045","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2036.2012.05080.x","article-title":"Review article: fructose in non-alcoholic fatty liver disease","volume":"35","author":"Yilmaz","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.05.072_b0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.05.072_b0060","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0065","first-page":"21","article-title":"Molecular cloning of a differentiation-related mRNA in the adipogenic cell line 1246","volume":"3","author":"Jiang","year":"1992","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbrc.2014.05.072_b0070","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0022-2275(20)34939-7","article-title":"Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein","volume":"38","author":"Brasaemle","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2014.05.072_b0075","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/01.ATV.0000223345.11820.da","article-title":"Adipocyte differentiation-related protein promotes fatty acid storage in cytosolic triglycerides and inhibits secretion of very low-density lipoproteins","volume":"26","author":"Magnusson","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbrc.2005.12.121","article-title":"Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet","volume":"340","author":"Motomura","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.05.072_b0085","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1194\/jlr.M015859","article-title":"Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis","volume":"52","author":"Ge","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2014.05.072_b0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1194\/jlr.M600471-JLR200","article-title":"NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes","volume":"48","author":"Laurencikiene","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2014.05.072_b0095","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1053\/j.gastro.2007.02.046","article-title":"Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide","volume":"132","author":"Imai","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2014.05.072_b0100","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00535-007-2119-8","article-title":"Lipopolysaccharide induces adipose differentiation-related protein expression and lipid accumulation in the liver through inhibition of fatty acid oxidation in mice","volume":"42","author":"Ohhira","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0105","first-page":"578","article-title":"Tumor necrosis factor-alpha upregulates the protein levels of adipose differentiation-related protein in rat differentiated adipocytes","volume":"40","author":"Liu","year":"2008","journal-title":"Beijing DaXue XueBao"},{"key":"10.1016\/j.bbrc.2014.05.072_b0110","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.05.072_b0115","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1194\/jlr.M007179","article-title":"Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice","volume":"51","author":"Volynets","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2014.05.072_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2014.04.048","article-title":"Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis","volume":"448","author":"Wu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.05.072_b0125","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbrc.2014.05.072_b0130","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14009449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14009449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:17:57Z","timestamp":1649089077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14009449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0006291X14009449"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.072","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}